Dr. Reddy’s launches generic ARICEPT, EFFEXOR XR and FEMARA in the US

Dr. Reddy's Laboratories (NYSE: RDY) today announced that it has launched the following three products in the US market:

• Donepezil Hydrochloride tablets (5mg and 10mg strengths), a bioequivalent generic version of ARICEPT® tablets. The Food & Drug Administration (FDA) approved Dr. Reddy's ANDA for Donepezil HCl tablets on May 31, 2011. Both strengths of Dr. Reddy's Donepezil Hydrochloride tablets are available in 30, 90 and 500 count bottles.
• Venlafaxine Hydrochloride Extended Release capsules (37.5mg, 75mg and 150mg strengths), a bioequivalent generic version of EFFEXOR XR® Extended Release capsules. The Food & Drug Administration (FDA) approved Dr. Reddy's ANDA for Venlafaxine Hydrochloride Extended Release Capsules on May 05, 2011. All three strengths of Dr. Reddy's Venlafaxine Hydrochloride Extended Release Capsules are available in 30, 90 and 500 count bottles.
• Letrozole tablets, USP (2.5mg), a bioequivalent generic version of FEMARA®. The Food & Drug Administration (FDA) approved Dr. Reddy's ANDA for Letrozole tablets, USP on June 3, 2011. Dr. Reddy's Letrozole tablets, USP are available in 30 count bottles.

SOURCE Dr. Reddy's Laboratories Ltd.